This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Monitoring whilst taking antithyroid drugs

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The CSM and MCA have made the following recommendations:

  • patients taking antithyroid drugs should be asked to report symptoms suggestive of infection particularly sore throat

  • if there is clinical evidence of infection then a FBC should be performed

  • if there is clinical or laboratory evidence of neutropenia then the antithyroid drug should be stopped

  • routine FBC monitoring is not indicated (1)

Reference:

  • Current Problems in Pharmacovigilance (February 1999), 25, 1-4.

Related pages

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page